Clinical Trial Update: Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cyclophosphamide with rabbit antithymocyte globulin (rATG) or rituximab in systemic lupus erythematosus has completed and results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Rituximab (rituximab)
• rabbit antithymocyte globulin (rabbit antithymocyte globulin)

Snippet

Sponsor: Northwestern University | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2020-02-28